In this episode of Meeting Mic, we bring you pearls and perspectives from the 2025 ASCO Annual Meeting, as well as Healio’s top headlines from the meeting.

Chinmay Jani, MD, discusses findings highlighting how alcohol-related cancer mortality has risen sharply over the past few decades. :19

Rachel I. Vogel, PhD, provides and overview on factors contributing to the time burden cancer care places on patients. 3:02

Alexander D. Sherry, MD, discusses how improvements in OS or quality of life after phase 3 oncology trials are based on improvements in unvalidated alternative endpoints. 4:41

Lucas A. Mavromatis, ScB, discusses findings on how GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes. 7:20

Sonali M. Smith, MD, talks with Oncology Overdrive host Shikha Jain, MD, about presentations on lymphoma at this year’s ASCO meeting. 9:57

Read the full coverage here:

https://www.healio.com/news/hematology-oncology/20250531/study-reveals-shocking-rise-in-alcoholrelated-cancer-deaths

https://www.healio.com/news/hematology-oncology/20250603/time-burden-people-with-cancer-face-often-vastly-underestimated

https://www.healio.com/news/hematology-oncology/20250604/few-phase-3-oncology-trials-demonstrate-improvements-in-os-quality-of-life

https://www.healio.com/news/hematology-oncology/20250522/glp1-receptor-agonists-confer-modest-protection-against-obesityrelated-cancers

https://www.healio.com/news/hematology-oncology/podcasts/oncology-overdrive/episode-119

Exercise described as ‘novel, first-in-class’ colon cancer therapy

Source: Booth CM, et al. Abstract LBA3510. Presented at: ASCO Annual Meeting; May 30-June 3, 2025; Chicago.

At-home intervention has potential to enhance cancer care delivery, outcomes

Source: Nipp RD, et al. Abstract 11003. Presented at: ASCO Annual Meeting; May 30-June 3, 2025; Chicago.

Disclosures:

Jani reports no relevant financial disclosures. Mavromatis reports no relevant financial disclosures. Sherry reports honoraria from Sermo.  Smith reports no relevant financial disclosures. Vogel reports a consulting/advisory role with Voluntis.